U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Clear Cell Renal Cell Carcinoma

MedGen UID:
1650549
•Concept ID:
C4727378
•
Neoplastic Process

Definition

The reemergence of clear cell renal cell carcinoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Clear Cell Renal Cell Carcinoma

Professional guidelines

PubMed

French AFU Cancer Committee Guidelines - Update 2022-2024: management of kidney cancer.
Bigot P, Barthelemy P, Boissier R, Khene ZE, Pettenati C, Bernhard JC, Correas JM, Doumerc N, Gimel P, Ingels A, Nouhaud FX, Ouzaïd I, Rioux-Leclercq N, Albiges L, Rouprêt M
Prog Urol 2022 Nov;32(15):1195-1274. doi: 10.1016/j.purol.2022.07.146. PMID: 36400482
Clinical Utility of Cell-free and Circulating Tumor DNA in Kidney and Bladder Cancer: A Critical Review of Current Literature.
Green EA, Li R, Albiges L, Choueiri TK, Freedman M, Pal S, Dyrskjøt L, Kamat AM
Eur Urol Oncol 2021 Dec;4(6):893-903. Epub 2021 May 8 doi: 10.1016/j.euo.2021.04.005. PMID: 33975782
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.
Rouprêt M, Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Cowan NC, Dominguez-Escrig JL, Gontero P, Hugh Mostafid A, Palou J, Peyronnet B, Seisen T, Soukup V, Sylvester RJ, Rhijn BWGV, Zigeuner R, Shariat SF
Eur Urol 2021 Jan;79(1):62-79. Epub 2020 Jun 24 doi: 10.1016/j.eururo.2020.05.042. PMID: 32593530

Recent clinical studies

Etiology

Cediranib monotherapy in patients with advanced renal cell carcinoma: results of a randomised phase II study.
Mulders P, Hawkins R, Nathan P, de Jong I, Osanto S, Porfiri E, Protheroe A, van Herpen CM, Mookerjee B, Pike L, Jürgensmeier JM, Gore ME
Eur J Cancer 2012 Mar;48(4):527-37. Epub 2012 Jan 28 doi: 10.1016/j.ejca.2011.12.022. PMID: 22285180

Therapy

Insulin-mediated hypoglycaemia secondary to recurrent clear cell renal carcinoma.
Gogna G, Patel N, Bilinski P
J R Coll Physicians Edinb 2016 Dec;46(4):238-240. doi: 10.4997/JRCPE.2016.405. PMID: 28504776
Cediranib monotherapy in patients with advanced renal cell carcinoma: results of a randomised phase II study.
Mulders P, Hawkins R, Nathan P, de Jong I, Osanto S, Porfiri E, Protheroe A, van Herpen CM, Mookerjee B, Pike L, Jürgensmeier JM, Gore ME
Eur J Cancer 2012 Mar;48(4):527-37. Epub 2012 Jan 28 doi: 10.1016/j.ejca.2011.12.022. PMID: 22285180

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...